Upstream Bio ($UPB) Insider Trading & Smart Money Activity
Upstream Bio, Inc. ($UPB) has 5 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($30.62K), net -$30.62K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 5
- Net insider $ (12 mo)
- -$30.62K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
UPB insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 5 · $30.62K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All UPB insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Sutherland Everett RandChief Executive Officer | Sell (Open-market sale) | 2.10K sh | $12.78K | +6.8% | +22.1% | — | ||||
| Insider | Adam HoughtonChief Business Officer | Sell (Open-market sale) | 700 sh | $4.27K | +6.8% | +22.1% | — | ||||
| Insider | Michael GrayCFO and COO | Sell (Open-market sale) | 853 sh | $5.20K | +6.8% | +22.1% | — | ||||
| Insider | Aaron DeykinChief Medical Officer | Sell (Open-market sale) | 895 sh | $5.46K | +6.8% | +22.1% | — | ||||
| Insider | Allison AmbroseGeneral Counsel | Sell (Open-market sale) | 477 sh | $2.91K | +6.8% | +22.1% | — | ||||
| Analyst | JP Morgan | Lowers to hold | PT $8 | +3.3% | +19.3% | Read | |||||
| Analyst | JP Morgan | Lowers to hold | PT $8 | +3.3% | +19.3% | Read |
1W / 1M / 6M = how UPB moved from the trade or filing date.
Insider trading in UPB: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Sutherland Everett Rand | Chief Executive Officer | 1 | -$12.78K | Jun 16, 2026 | |
| Adam Houghton | Chief Business Officer | 1 | -$4.27K | Jun 16, 2026 | |
| Michael Gray | CFO and COO | 1 | -$5.20K | Jun 16, 2026 | |
| Aaron Deykin | Chief Medical Officer | 1 | -$5.46K | Jun 16, 2026 | |
| Allison Ambrose | General Counsel | 1 | -$2.91K | Jun 16, 2026 |
Analyst ratings on UPB
Frequently asked questions
Are UPB insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 5 open-market sales worth $30.62K, a net -$30.62K.
What is the latest insider trade in UPB?
Sutherland Everett Rand, Chief Executive Officer filed a sell (open-market sale) of 2.10K sh worth $12.78K on Jun 16, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.